1. Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study. Issue 6 (30th July 2014) Authors: Hézode, Christophe; Hirschfield, Gideon M; Ghesquiere, Wayne; Sievert, William; Rodriguez-Torres, Maribel; Shafran, Stephen D; Thuluvath, Paul J; Tatum, Harvey A; Waked, Imam; Esmat, Gamal; Lawitz, Eric J; Rustgi, Vinod K; Pol, Stanislas; Weis, Nina; Pockros, Paul J; Bourlière, Marc; Serfaty, Law... Journal: Gut Issue: Volume 64:Issue 6(2015) Page Start: 948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Drug hepatotoxicity. (2017) Editors: Rustgi, Vinod K; Gitlin, Norman Record Type: Book Extent: 1 online resource (276 pages), illustrations View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hepatic encephalopathy. (2020) Authors: Elsevier Clinics Editors: Rustgi, Vinod K Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C. (June 2012) Authors: Gao, Xin; Stephens, Jennifer M; Carter, John A; Haider, Seema; Rustgi, Vinod K Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 12:Number 3(2012) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C. (June 2012) Authors: Gao, Xin; Stephens, Jennifer M; Carter, John A; Haider, Seema; Rustgi, Vinod K Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 12:Number 3(2012) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C. (June 2012) Authors: Gao, Xin; Stephens, Jennifer M; Carter, John A; Haider, Seema; Rustgi, Vinod K Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 12:Number 3(2012) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Randomized Study of Asunaprevir plus Pegylated Interferon-α and Ribavirin for Previously Untreated Genotype 1 Chronic Hepatitis C. Issue 7 (October 2013) Authors: Bronowicki, Jean-Pierre; Pol, Stanislas; Thuluvath, Paul J; Larrey, Dominique; Martorell, Claudia T; Rustgi, Vinod K; Morris, David W; Younes, Ziad; Fried, Michael W; Bourlière, Marc; Hézode, Christophe; Reddy, K Rajender; Massoud, Omar; Abrams, Gary A; Ratziu, Vlad; He, Bing; Eley, Timothy; Ahma... Journal: Antiviral therapy Issue: Volume 18:Issue 7(2013) Page Start: 885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Thymalfasin for the treatment of chronic hepatitis C infection. Issue 6 (December 2005) Authors: Rustgi, Vinod K Journal: Expert review of anti-infective therapy Issue: Volume 3:Issue 6(2005) Page Start: 885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Issue 1 (26th August 2011) Authors: Thompson, Alexander J; Patel, Keyur; Chuang, Wan-Long; Lawitz, Eric J; Rodriguez-Torres, Maribel; Rustgi, Vinod K; Flisiak, Robert; Pianko, Stephen; Diago, Moises; Arora, Sanjeev; Foster, Graham R; Torbenson, Michael; Benhamou, Yves; Nelson, David R; Sulkowski, Mark S; Zeuzem, Stefan; Pulkstenis,... Journal: Gut Issue: Volume 61:Issue 1(2012) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗